000			01592 a2200457 4500
005			20250516163813.0
264		0	_c20140127
008			201401s 0 0 eng d
022			_a1524-4539
024	7		_a10.1161/CIRCULATIONAHA.113.002236 _2doi
040			_aNLM _beng _cNLM
100	1		_aDouiri, Abdel
245	0	0	_aLong-term effects of secondary prevention on cognitive function in stroke patients. _h[electronic resource]
260			_bCirculation _cSep 2013
300			_a1341-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntihypertensive Agents _xtherapeutic use
650	0	4	_aAspirin _xtherapeutic use
650	0	4	_aCognition Disorders _xdrug therapy
650	0	4	_aDipyridamole _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use
650	0	4	_aLongitudinal Studies
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPlatelet Aggregation Inhibitors _xtherapeutic use
650	0	4	_aPrevalence
650	0	4	_aRegistries _xstatistics & numerical data
650	0	4	_aRisk Factors
650	0	4	_aStroke _xdrug therapy
700	1		_aMcKevitt, Christopher
700	1		_aEmmett, Eva S
700	1		_aRudd, Anthony G
700	1		_aWolfe, Charles D A
773	0		_tCirculation _gvol. 128 _gno. 12 _gp. 1341-8
856	4	0	_uhttps://doi.org/10.1161/CIRCULATIONAHA.113.002236 _zAvailable from publisher's website
999			_c22994421 _d22994421